Try a new search

Format these results:

Searched for:

in-biosketch:true

person:rosena23

Total Results:

548


Standards of Reporting for MRI-targeted Biopsy Studies (START) of the Prostate: Recommendations from an International Working Group

Moore, Caroline M; Kasivisvanathan, Veeru; Eggener, Scott; Emberton, Mark; Futterer, Jurgen J; Gill, Inderbir S; Grubb Iii, Robert L; Hadaschik, Boris; Klotz, Laurence; Margolis, Daniel J A; Marks, Leonard S; Melamed, Jonathan; Oto, Aytekin; Palmer, Suzanne L; Pinto, Peter; Puech, Philippe; Punwani, Shonit; Rosenkrantz, Andrew B; Schoots, Ivo G; Simon, Richard; Taneja, Samir S; Turkbey, Baris; Ukimura, Osamu; van der Meulen, Jan; Villers, Arnauld; Watanabe, Yuji
BACKGROUND: A systematic literature review of magnetic resonance imaging (MRI)-targeted prostate biopsy demonstrates poor adherence to the Standards for the Reporting of Diagnostic Accuracy (STARD) recommendations for the full and transparent reporting of diagnostic studies. OBJECTIVE: To define and recommend Standards of Reporting for MRI-targeted Biopsy Studies (START). DESIGN, SETTING, AND PARTICIPANTS: Each member of a panel of 23 experts in urology, radiology, histopathology, and methodology used the RAND/UCLA appropriateness methodology to score a 258-statement premeeting questionnaire. The collated responses were presented at a face-to-face meeting, and each statement was rescored after group discussion. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Measures of agreement and consensus were calculated for each statement. The most important statements, based on group median score, the degree of group consensus, and the content of the group discussion, were used to create a checklist of reporting criteria (the START checklist). RESULTS AND LIMITATIONS: The strongest recommendations were to report histologic results of standard and targeted cores separately using Gleason score and maximum cancer core length. A table comparing detection rates of clinically significant and clinically insignificant disease by targeted and standard approaches should also be used. It was recommended to report the recruitment criteria for MRI-targeted biopsy, prior biopsy status of the population, a brief description of the MRI sequences, MRI reporting method, radiologist experience, and image registration technique. There was uncertainty about which histologic criteria constitute clinically significant cancer when the prostate is sampled using MRI-targeted biopsy, and it was agreed that a new definition of clinical significance in this setting needed to be derived in future studies. CONCLUSIONS: Use of the START checklist would improve the quality of reporting in MRI-targeted biopsy studies and facilitate a comparison between standard and MRI-targeted approaches.
PMID: 23537686
ISSN: 0302-2838
CID: 305162

Does Suspicion of Prostate Cancer on Integrated T2 and Diffusion-weighted MRI Predict More Adverse Pathology on Radical Prostatectomy?

Borofsky, Michael S; Rosenkrantz, Andrew B; Abraham, Nitya; Jain, Rajat; Taneja, Samir S
OBJECTIVE: To determine whether suspicion for tumor on prostate MRI incorporating T2-weighted imaging (T2-WI) and diffusion-weighted imaging (DWI) predicts more adverse pathology on radical prostatectomy (RP). METHODS: From 2007 to 2009, 154 patients underwent 1.5 Tesla pelvic-phased-array magnetic resonance imaging (MRI) of the prostate that included T2-WI and DWI before RP. MRI examinations were retrospectively reviewed and grouped by degree of suspicion for tumor: no suspicion for tumor (NST, n = 15), equivocal suspicion for tumor (EST, n = 60), or strong suspicion for tumor (SST, n = 79). The NST/EST groups were combined and compared to the SST group. Preoperative variables were used to assemble a multivariate model. Outcomes reflective of adverse pathology included primary Gleason grade >/=4, pathologic stage >/=T3 (>/=pT3), and tumor upgrading. Subgroup analysis was performed for patients meeting eligibility criteria for active surveillance (n = 55). For this analysis, the NST group was compared to the EST/SST groups. RESULTS: SST status was associated with adverse preoperative risk factors for aggressive disease. Univariate analysis demonstrated significant association between SST and primary Gleason >/=4 pathology and stage >/=pT3 (P <.05). On multivariate analysis, SST was independently predictive of primary Gleason >/=4 pathology (odds ratio [OR] 6.14, 95% confidence interval [CI] 1.97-19.2) and Gleason upgrading (OR 2.47, 95% CI 1.01-6.02). Among patients eligible for active surveillance, those in the NST group had decreased likelihood of Gleason >/=7 disease or stage >/=pT3 compared to the EST/SST groups (7.7% vs 47.6%, P = .01). CONCLUSION: Increased tumor suspicion on T2-WI/DWI MRI is indicative of adverse pathology on RP. These findings suggest a role for MRI in pretreatment risk assessment.
PMID: 23394882
ISSN: 0090-4295
CID: 305182

Recommendations for additional imaging on emergency department CT examinations: comparison of emergency- and organ-based subspecialty radiologists

Rosenkrantz, Andrew B; Matza, Brent W; Foran, Mark P; McMenamy, John M
PURPOSE: Past studies have identified a high frequency of recommendations for additional imaging (RAI) for computed tomography (CT) studies performed in an emergency department (ED), thereby potentially contributing to increased imaging utilization and costs. The purpose of this study was to compare rates of RAI within the ED setting between ED-based and organ-based subspecialty radiologists. METHODS: We identified 600 ED CT studies, comprising 200 head, chest, and abdominal CT studies, split equally between cases reviewed by ED-based and organ-based radiologists. Frequency of RAI for the three examinations was compared between these subspecialty groups. RESULTS: Frequencies of RAI were 21.5 %, 13.5 %, and 5.5 % for CT examinations of the chest, abdomen, and brain, respectively. There was a significantly higher frequency of RAI for chest CT studies interpreted by chest radiologists than by ED radiologists (28.0 % vs. 15.0 %, respectively, p = 0.036), largely due to a higher rate of RAI for incidentally detected lung nodules and masses as well as other pulmonary parenchymal abnormalities by chest radiologists. There was no significant difference in RAI on brain or abdominal CT studies between the two groups (p = 0.426-1.0). However, on abdominal studies, only ED-based radiologists provided RAI for abnormalities of the bowel or uterus, while only organ-based radiologists provided RAI for pancreatic abnormalities. Only 25.6 % of RAI were subsequently performed at our institution. CONCLUSION: For chest CT studies performed at the authors' institution, differences in management of incidental pulmonary nodules contributed to a significantly higher frequency of RAI by chest radiologists than by ED-based radiologists. Further investigation of the impact of these differences on cost and patient outcomes is warranted.
PMID: 23053163
ISSN: 1070-3004
CID: 248112

Validation of a Gleason Score 7 Weighted Based on Proportion of Gleason 4 Component (Quantitative Gleason Score) as Predictor of Biochemical Recurrencee after Radical Prostatectomy [Meeting Abstract]

Deng, F-M; Benito, R. Pe; Donin, N.; Rosenkrantz, A.; Zhou, M.; Lepor, H.; Taneja, S.; Melamed, J.
ISI:000314789301172
ISSN: 0023-6837
CID: 241052

Prostate cancer: Utility of diffusion-weighted imaging as a marker of side-specific risk of extracapsular extension

Rosenkrantz, Andrew B; Chandarana, Hersh; Gilet, Anthony; Deng, Fang-Ming; Babb, James S; Melamed, Jonathan; Taneja, Samir S
PURPOSE: To assess the utility of diffusion-weighted imaging (DWI) findings as an indirect marker of side-specific risk of extracapsular extension (ECE) of prostate cancer. MATERIALS AND METHODS: Fifty-one patients underwent 3T magnetic resonance imaging (MRI) before prostatectomy. Radiologists 1 and 2 (4 and 1 years experience) assessed each side for ECE using T2-weighted imaging (T2WI) and evaluated apparent diffusion coefficient (ADC) maps for the presence of apparent tumor in each lobe and to measure peripheral zone ADC. A uropathologist measured the extent of any ECE. RESULTS: In all, 28/102 lobes had ECE, of which 12 measured 1 mm and 2 mm. Side-specific accuracies for detection of ECE for readers 1 and 2 were respectively: T2WI 68.6% and 74.5%; presence of apparent tumor on ADC map 66.7% and 60.8%; ADC value 75.5% and 69.6%. For ECE >2 mm, both readers achieved 100% sensitivity based on apparent tumor on ADC map or ADC values and 80% sensitivity using T2WI. For detection of ECE
PMID: 23238968
ISSN: 1053-1807
CID: 231622

Diffusion-weighted imaging of the prostate: Comparison of b1000 and b2000 image sets for index lesion detection

Rosenkrantz, Andrew B; Hindman, Nicole; Lim, Ruth P; Das, Kasturi; Babb, James S; Mussi, Thais C; Taneja, Samir S
PURPOSE: To compare tumor detection on acquired diffusion-weighted (DW) images and apparent diffusion coefficient (ADC) maps, obtained using b-values of 1000 s/mm(2) and 2000 s/mm(2) , using radical prostatectomy as the reference. MATERIALS AND METHODS: In all, 29 prostate cancer patients who underwent 3T magnetic resonance imaging (MRI) including DW imaging using b-values of 1000 s/mm(2) and 2000 s/mm(2) were included. Two radiologists independently evaluated four image sets during different sessions and recorded the location and diameter of the dominant lesion: DW images acquired using b-values of 1000 s/mm(2) and 2000 s/mm(2) and ADC maps calculated using maximal b-values of 1000 s/mm(2) and 2000 s/mm(2) . Findings were correlated with the location and diameter of the dominant lesion at prostatectomy. Tumor-to-PZ contrast was also calculated, unblinded to pathology. RESULTS: Both readers achieved significantly higher sensitivity for DW images obtained using a b-value of 2000 s/mm(2) than 1000 s/mm(2) (P < 0.001), although there was no difference in sensitivity between ADC maps calculated using the two b-values (P >/= 0.309). Tumor-to-PZ contrast was higher for DW images using a b-value of 2000 s/mm(2) (P = 0.067), although it was not different between the two corresponding ADC maps (P = 0.544). For both readers, correlations with tumor diameters were higher for either ADC map (r = 0.59-0.73) than for either acquired DW image set (r = 0.03-0.57). CONCLUSION: Use of a b-value of 2000 s/mm(2) compared with a b-value of 1000 s/mm(2) resulted in improved tumor sensitivity and higher tumor-to-PZ contrast on the acquired DW images, although performance of the ADC maps corresponding with the two b-values was similar. Correlation with tumor size was greater for either ADC map than for either acquired DW image set. J. Magn. Reson. Imaging 2013;. (c) 2013 Wiley Periodicals, Inc.
PMID: 23371846
ISSN: 1053-1807
CID: 231592

Pancreatic cancer: Lack of association between apparent diffusion coefficient values and adverse pathological features

Rosenkrantz, A B; Matza, B W; Sabach, A; Hajdu, C H; Hindman, N
AIM: To identify retrospectively potential associations between apparent diffusion coefficient (ADC) values of pancreatic adenocarcinoma and tumour grade as well as other pathological features, using histopathological assessment from the Whipple procedure as the reference standard. MATERIALS AND METHODS: Thirty patients with pancreatic adenocarcinoma underwent magnetic resonance imaging (MRI) including diffusion-weighted imaging with b-values of 0 and 500 s/mm before the Whipple procedure. Two radiologists independently recorded the ADC values of the tumour and benign pancreas for all cases. ADC values were compared with histopathological findings following the Whipple procedure. RESULTS: The intra-class correlation coefficient was 0.689 for benign pancreas and 0.695 for tumours, indicating good inter-reader agreement for ADC values. The mean ADC value was significantly lower in tumours than in benign pancreas for both readers (reader 1: 1.74 +/- 0.34 x 10 mm/s versus 2.08 +/- 0.48 x 10 mm/s, respectively, p = 0.006; reader 2: 1.69 +/- 0.41 x 10 mm/s versus 2.11 +/- 0.54 x 10 mm/s, respectively, p < 0.001). However, there was no significant difference in mean ADC between poorly and well/moderately differentiated tumours for either reader (reader 1: 1.69 +/- 0.36 x 10 mm/s versus 1.78 +/- 0.33 x 10 mm/s, respectively, p = 0.491; reader 2: 1.62 +/- 0.33 x 10 mm/s versus 1.75 +/- 0.49 x 10 mm/s, respectively, p = 0.405). The area under the curve (AUC) for differentiation of poorly and well/moderately differentiated tumours was 0.611 and 0.596 for readers 1 and 2, respectively, and was not significantly better than an AUC of 0.500 for either reader (p >/= 0.306). In addition, ADC was not significantly different for either reader between tumours with stage T3 versus stage T1/T2, between tumours with and without metastatic peri-pancreatic lymph nodes, or between tumours located in the pancreatic head versus other pancreatic regions (p >/= 0.413). CONCLUSION: No associations between ADC values of pancreatic adenocarcinoma and tumour grade or other adverse pathological features were observed.
PMID: 23312674
ISSN: 0009-9260
CID: 231192

Validation of a Gleason Score 7 Weighted Based on Proportion of Gleason 4 Component (Quantitative Gleason Score) as Predictor of Biochemical Recurrencee after Radical Prostatectomy [Meeting Abstract]

Deng, F-M; Benito, R. Pe; Donin, N.; Rosenkrantz, A.; Zhou, M.; Lepor, H.; Taneja, S.; Melamed, J.
ISI:000314444401252
ISSN: 0893-3952
CID: 227302

Prognostic implications of the magnetic resonance imaging appearance in papillary renal cell carcinoma

Rosenkrantz, Andrew B; Sekhar, Aarti; Genega, Elizabeth M; Melamed, Jonathan; Babb, James S; Patel, Amish D; Lo, Andy; Najarian, Robert M; Ahmed, Muneeb; Pedrosa, Ivan
OBJECTIVE: To evaluate the prognostic implications of the MRI appearance and pathological features of papillary renal cell carcinoma (pRCC). METHODS: A total of 128 pRCC in 115 patients who underwent preoperative MRI were characterised in terms of pathological type (type 1 vs. type 2), MRI appearance (focal vs. infiltrative) and additional MRI features. Patients were classified on the basis of the presence or absence of metastatic disease. RESULTS: There were 65 focal type 1, 54 focal type 2 and 9 infiltrative pRCC. All infiltrative pRCC were of histopathological type 2. Renal vein thrombus was present in 89 % of infiltrative pRCC and no cases of focal pRCC. Metastatic disease was observed in 3.7 % of focal type 1, 7.5 % of focal type 2 and 75.0 % of infiltrative type 2 pRCC. Infiltrative MRI appearance was a significant predictor of metastatic disease, independent of pathological type, size and T stage (P 0.5). CONCLUSION: Infiltrative MRI appearance and renal vein thrombus identify a subset of pathological type 2 pRCC at a significantly increased risk of metastatic disease.
PMID: 22903703
ISSN: 0938-7994
CID: 220682

Histogram-based apparent diffusion coefficient analysis: an emerging tool for cervical cancer characterization?

Rosenkrantz, Andrew B
OBJECTIVE: Numerous prior studies have shown the utility of apparent diffusion coefficient values in cervical cancer assessment, particularly in differentiation from benign cervix. This article will discuss histogram-based analysis for detection of adverse histologic features of cervical cancer. CONCLUSION: The study by Downey et al. in this issue investigates histogram-based analysis for detection of adverse histologic features of cervical cancer, including subtype and grade. This approach offers a more complete assessment of tumor texture and heterogeneity. Given the potential utility suggested by the results of this study, additional larger studies are warranted.
PMID: 23345351
ISSN: 0361-803x
CID: 213782